Literature DB >> 1934172

Human pre-interleukin 1 alpha and beta: structural features revealed by limited proteolysis.

Y Kobayashi1, J J Oppenheim, K Matsushima.   

Abstract

Both pre-interleukin 1 alpha and beta (pre IL 1 alpha and beta) are proteolytically processed into extracellular mature forms of IL 1 alpha and beta. Since pre IL 1 alpha is shown to be biologically active, there may be other reasons for the proteolytic processing of IL 1 alpha and presumably, for IL 1 beta also. In order to examine the possibility that structural stabilization may be associated with the proteolytic processing of pre IL 1 alpha and beta, we investigated the structural features of pre IL 1 alpha and beta by the combination of limited proteolysis and immunoprecipitation with antibodies to the NH2-terminal halves or COOH-terminal halves of pre IL 1 alpha or beta. Both trypsin and V8 protease digested the NH2-terminal halves of pre IL 1 alpha and beta more easily than the COOH-terminal halves of pre IL 1 alpha and beta, yielding structurally stabilized "mature" forms of IL 1. Both trypsin and V8 protease yielded a fragment similar in size to mature IL 1 alpha from pre IL 1 alpha. In contrast, trypsin digested pre IL 1 beta into fragments smaller in size than mature IL 1 beta, while V8 protease yielded a fragment similar in size to mature IL 1 beta. Furthermore, mature IL 1 beta, once processed and released from cells, was resistant to trypsin.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1934172     DOI: 10.1248/cpb.39.1513

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  5 in total

1.  Effects of serine protease inhibitor, TAME, on IL-1 beta in LPS-stimulated human monocytes: relationship between synthesis and release of a 33-kDa precursor and the 17-kDa biologically active species.

Authors:  J J Jessop; S L Henry; T Hoffman
Journal:  Inflammation       Date:  1993-10       Impact factor: 4.092

2.  Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice.

Authors:  Yehuda Kamari; Aviv Shaish; Einav Vax; Shay Shemesh; Michal Kandel-Kfir; Yaron Arbel; Sarita Olteanu; Iris Barshack; Shahar Dotan; Elana Voronov; Charles A Dinarello; Ron N Apte; Dror Harats
Journal:  J Hepatol       Date:  2011-02-24       Impact factor: 25.083

Review 3.  Cytokines in human milk: properties and potential effects upon the mammary gland and the neonate.

Authors:  A S Goldman; S Chheda; R Garofalo; F C Schmalstieg
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-07       Impact factor: 2.673

Review 4.  Acute-phase protein α1-anti-trypsin: diverting injurious innate and adaptive immune responses from non-authentic threats.

Authors:  O Guttman; B M Baranovski; R Schuster; Z Kaner; G S Freixo-Lima; N Bahar; N Kalay; M I Mizrahi; I Brami; D E Ochayon; E C Lewis
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

5.  Pro-interleukin (IL)-1beta shares a core region of stability as compared with mature IL-1beta while maintaining a distinctly different configurational landscape: a comparative hydrogen/deuterium exchange mass spectrometry study.

Authors:  Kendra L Hailey; Sheng Li; Mette D Andersen; Melinda Roy; Virgil L Woods; Patricia A Jennings
Journal:  J Biol Chem       Date:  2009-07-10       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.